Dan Turner

Tobira Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company, which focuses on developing and commercializing of therapies to treat liver disease, HIV, fibrosis and inflammation. Its lead product candidate, cenicriviroc or CVC, is a proprietary immunomodulator that may be used to treat a number of diseases, including NASH, kidney fibrosis, HIV-1 and others. The company was founded by Eckard Weber in September 2006 and is headquartered in South San Francisco, CA.

Sequel Pharmaceuticals, Inc. engaged in the development of cardiovascular drug. The company was founded in 2007 and was headquartered in San Diego, CA.

Transcept Pharmaceuticals, Inc. is a specialty pharmaceutical company focused on the development and commercialization of proprietary products that address important therapeutic needs in the field of neuroscience. Its product pipeline is TO-2070, a novel, rapidly absorbed treatment for acute migraine incorporating dihydroergotamine as the active drug. The company was founded on January 30, 2009 and is headquartered in Point Richmond, CA.

Oclassen Pharmaceuticals Inc, headquartered in San Rafael, CA develops and markets specialty pharmaceuticals for the prevention, diagnosis and treatment of skin diseases. Oclassen Pharmaceuticals develops and markets products for the dermatology and wound-care markets.

Renal CarePartners, Inc. owns and operates a network of kidney dialysis clinics for the treatment of end-stage renal disease in the United States. The firm offers in-center therapies. It also provides home therapies, including daily, nocturnal, and staff assisted home hemodialysis; and peritoneal, continuous cycling peritoneal, and continuous ambulatory peritoneal dialysis. The company was founded in 2002 and is headquartered in Hollywood, FL.

Part of Rocket Software, Inc., Renex Corp. specializes in web-based emulation projects for mainframe and midrange applications. The company is based in Pittsburgh, PA. Renex was acquired by Seagull Holdings NV, part of Rocket Software, Inc. from April 27, 2007 on April 27, 2001 for $0.91 million. The company was founded by Robert Peter Thian. Robert Peter Thian has been the CEO since incorporation.

moksha8 Pharmaceuticals, Inc. operates as a pharmaceutical company. It's products include viibryd, razapina, queopine, benexafrina, arasid, ziledon, zopina, and rispalum. The firm offers a portfolio of therapeutics for bipolar disorders and schizophrenia. The company was founded by Balkrishan Gill in 2007 and is headquartered in Berwyn, PA.

Global Consolidated Aesthetics Ltd. develops, manufactures and sells breast implants. It offers products under flagship brands Nagor and Eurosilicone. The firm manufactures products at its own facilities based in Scotland, England and France and produces to the highest European standards. The company was founded in 2007 and is headquartered in Dublin, Ireland.

Berkeley VC International LLC (Berkeley VC International) is venture capital firm founded in 1977 by Arthur I. Trueger. The firm is headquartered in San Francisco, California.

Cerexa, Inc. develops biopharmaceutical products. It is focuses on developing, acquiring and commercializing antibiotics to treat life-threatening, hospital-based infections. Cerexa's compound PPI-0903 is a cephalosporin used in treatment for complicated skin and skin-structure infections, as well as community-acquired and hospital-acquired pneumonias. The company was founded in 2005 and is headquartered in Alameda, CA.

Peninsula Pharmaceuticals, Inc. used to develop and commercialize antibiotics to treat life threatening infections. The company used to develop optimal anti-infective therapies that offer improved efficacy, dosing and safety characteristics over existing therapies. It was founded in 2001. The company was located in Alameda, CA.

GC Aesthetics Plc designs, manufactures and distribute implantable medical devices. The firm operates through two brands: Nagor and Eurosilicone. Its global aesthetics products market includes the following segments: breast implant products, skin tightening and body shaping, energy devices, neuro modulators, dermal fillers, chemical peels, liposuctions, self and physician dispensed topical and injectables, removal of localized fat deposits, device-based alternatives to toxins for wrinkle reduction and therapy treatments for hair loss, excessive sweating (hyperhidrosis), malfunctioning veins (sclerotherapy) and scars. The company was founded by William McCabe in April 2015 and is headquartered in Dublin, Ireland.

Avantis Medical Systems, Inc. develops and manufactures devices for the detection of cancer in the gastrointestinal tract. Its products include single camera colonoscopy and third eye panoramic device. The company was founded by Fred R. Seddiqui and David Watts in 2004 and is headquartered in San Jose, CA.

Pure Life Renal, Inc. provides dialysis services. The firm offers the business and operational management tools along with the administrative structure that enable physicians to concentrate on care in a managed environment. The company was founded by Stefano Ciampolini in 2013 and is headquartered in Hollywood, FL.

Colorescience Corp. manufactures and sells mineral based makeup products. It offers bronzer, blusher, concealer, powder, eye shadow, eye-liner, lip-gloss, and lip liner, blush blenders, eye blenders, shaper brushes, eyelash curlers, and application sponges. The company was founded by Diane Richardson Ranger in 2000 and is headquartered in Carlsbad, CA.

Montreux IV Associates IV LLC provides pooled Investment firm. The company is headquartered in San Francisco, CA.

Crown Laboratories, Inc. provides pharmaceutical and consumer products. Its products include aesthetics, beauty, therapeutic and prescription products. The firm offers contract development, manufacturing, production and packaging servicers. The company was founded by Don Kilday and Jeff Bedard in November 2000 and is headquartered in Johnson City, TN.